DrugDashboards
← Home
Manufacturing facility

Laurus Labs Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β€” so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Plot No. 19, 20 & 21, Western Sector APSEZ Gurajapalem Village, Rambilli Mandal, Anakapalli, Andhra Pradesh 531011, India (IND)
Operations here
analysisapi manufacturemanufacture
FDA identifiers
FEI 3011538548 Β· DUNS 650885309

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-02-10
  • NAIDrug Quality Assurance2017-05-19

Drugs this plant is listed as making

19 distinct drugs across 49 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.

Laurus Labs Limited β€” facility profile Β· DrugDashboards